Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet E Pope

Showing results (71-80 of 299) with videos related to

Pageof 30
Sort By:
Arthritis Care & Research|October 22, 2020
An Update of Outcome Measures in Systemic SclerosisTing Yi Jessica Chang, Janet E Pope
Rheumatology (Oxford, England)|May 13, 2009
The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysisDeanne Malenfant, Michelle Catton, Janet E Pope
Immunotherapy|July 10, 2020
How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatologyTing Yi Jessica Chang, Janet E Pope
Clinical and Experimental Rheumatology|April 6, 2013
A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databasesCorrine Coulter, Murray Baron, Janet E Pope
Rheumatology (Oxford, England)|August 27, 2020
Comment on: Incidence and prevalence of giant cell arteritis in Ontario, Canada: replyLillian Barra, Janet E Pope, Jessica Widdifield
Best Practice & Research. Clinical Rheumatology|March 12, 2023
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritisMargaret Man-Ger Sun, Janet E Pope
The Journal of Rheumatology|September 3, 2009
The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36Kim J Colangelo, Janet E Pope, Christine Peschken
Clinical and Experimental Rheumatology|February 28, 2017
A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factorsTatiana Nevskaya, Maeve P Gamble, Janet E Pope
The Journal of Rheumatology|February 13, 2002
Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologistsJanet E Pope, Paul Hong, Barry E Koehler
Autoimmunity Reviews|July 14, 2020
Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)Yuxuan Jiang, Matthew A Turk, Janet E Pope
Pageof 30

Showing results (71-80 of 299) with videos related to

Sort By:
Pageof 30
Arthritis Care & Research|October 22, 2020
An Update of Outcome Measures in Systemic SclerosisTing Yi Jessica Chang, Janet E Pope
Rheumatology (Oxford, England)|May 13, 2009
The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysisDeanne Malenfant, Michelle Catton, Janet E Pope
Immunotherapy|July 10, 2020
How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatologyTing Yi Jessica Chang, Janet E Pope
Clinical and Experimental Rheumatology|April 6, 2013
A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databasesCorrine Coulter, Murray Baron, Janet E Pope
Rheumatology (Oxford, England)|August 27, 2020
Comment on: Incidence and prevalence of giant cell arteritis in Ontario, Canada: replyLillian Barra, Janet E Pope, Jessica Widdifield
Best Practice & Research. Clinical Rheumatology|March 12, 2023
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritisMargaret Man-Ger Sun, Janet E Pope
The Journal of Rheumatology|September 3, 2009
The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36Kim J Colangelo, Janet E Pope, Christine Peschken
Clinical and Experimental Rheumatology|February 28, 2017
A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factorsTatiana Nevskaya, Maeve P Gamble, Janet E Pope
The Journal of Rheumatology|February 13, 2002
Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologistsJanet E Pope, Paul Hong, Barry E Koehler
Autoimmunity Reviews|July 14, 2020
Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)Yuxuan Jiang, Matthew A Turk, Janet E Pope
Pageof 30